Elotuzumab Market Overview: Multiple myeloma is a cancer that affects bone marrow plasma cells. Elotruzumab is a monoclonal antibody used to treat it. Targeting the SLAMF7 protein on myeloma cells specifically, elotuzumab enhances the immune system's ability to identify and eliminate cancerous cells. In addition to helping patients who have relapsed or are resistant to treatment, it...